Chat
Duchenne/Becker Muscular Dystrophy (DMD) Sequencing
2011153
Copy Utility
Ordering Recommendation
Mnemonic
DMD SEQ
Methodology
Massively Parallel Sequencing
Performed
Varies
Reported
2-4 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA) or yellow (ACD Solution A or B).
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Remarks
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable
Reference Interval
By report
Interpretive Data
Refer to report.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Counseling and informed consent are recommended for genetic testing. Consent forms are available online.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
N/A
CPT Codes
81408
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2011210 | DMD Sequencing Specimen | 31208-2 |
| 2011211 | DMD Sequencing Interpretation | 50626-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Dystrophinopathies
Duchenne/Becker Muscular Dystrophy (DMD) Sequencing
Feedback
